Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoPRAG: PRaG Therapy + Chemotherapy for Locally Advanced PDAC
NCT06345599Phase 2Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- May 2024
- Primary completion
- Jan 2027
- Modality
- Bispecific Antibodies
01
Overview
A Phase 2 trial of cadonilimab in pancreatic ductal adenocarcinoma (PDAC), sponsored by The Second Affiliated Hospital of Soochow University. Planned start May 2024; status: not yet recruiting.
02
Drugs
cadonilimab
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT06345599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06345599.